Literature DB >> 9557888

Characterization of a supernumerary marker derived from chromosome 17 by microdissection in an adult with MR/MCA.

C Kozma1, J Blancato, J Meck, Y Jiang.   

Abstract

We describe a 38-year-old adult who has a supernumerary marker chromosome in 40% of metaphase cells which was identified by reverse in situ hybridization with a DNA probe made by microdissection to be derived from chromosome 17. The breakpoints are estimated by G-banding and fluorescence in situ hybridization (FISH) to consist of the region from 17p11.1 to proximal 17q21. The propositus displayed severe growth retardation, kyphoscoliosis, bilateral cataracts, severe calcaneovalgus deformity of the feet, dysmorphic facies, profound mental retardation, and multiple medical problems requiring ongoing medical management. These problems included a mitral valve prolapse with regurgitation, recurrent upper and lower respiratory tract infections, and severe respiratory insufficiency. The relatively long survival of this patient enabled us to describe the natural history of this rare chromosomal mutation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557888

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  3 in total

1.  Small marker chromosomes in two patients with segmental aneusomy for proximal 17p.

Authors:  Christine J Shaw; Pawel Stankiewicz; Gabriel Bien-Willner; Scott C Bello; Chad A Shaw; Marta Carrera; Luis Perez Jurado; Xavier Estivill; James R Lupski
Journal:  Hum Genet       Date:  2004-04-20       Impact factor: 4.132

2.  Is there any link between joint hypermobility and mitral valve prolapse in patients with fibromyalgia syndrome?

Authors:  Erkan Kozanoglu; Ilke Coskun Benlidayi; Rabia Eker Akilli; Abdurrahman Tasal
Journal:  Clin Rheumatol       Date:  2015-07-28       Impact factor: 2.980

3.  Characterization of a de novo sSMC 17 detected in a girl with developmental delay and dysmorphic features.

Authors:  Lana Stavber; Sara Bertok; Jernej Kovač; Marija Volk; Luca Lovrečić; Tadej Battelino; Tinka Hovnik
Journal:  Mol Cytogenet       Date:  2017-03-23       Impact factor: 2.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.